As of Dec 09
| +0.04 / +0.35%|
The 3 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 33.00, with a high estimate of 36.00 and a low estimate of 26.00. The median estimate represents a +191.26% increase from the last price of 11.33.
The current consensus among 3 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.